Parkman Healthcare Partners’s Becton Dickinson BDX Stock Holding History

Parkman Healthcare Partners’s Portfolio BDX Stock Details BDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-120,283	Closed	-$27.6M	–	89
2025 Q1	$27.6M	Buy	120,283 +49,879	+71%	+$11.6M	3.27%	6
2024 Q4	$16M	Buy	70,404 +10,393	+17%	+$2.4M	2.13%	14
2024 Q3	$14.5M	Sell	60,011 -8,156	-12%	-$1.91M	1.85%	19
2024 Q2	$15.9M	Buy	68,167 +22,570	+49%	+$5.32M	2.13%	11
2024 Q1	$11.3M	Sell	45,597 -21,861	-32%	-$5.23M	1.38%	28
2023 Q4	$16.4M	Sell	67,458 -30,494	-31%	-$7.52M	2.32%	14
2023 Q3	$25.3M	Buy	97,952 +14,306	+17%	+$3.86M	4.64%	3
2023 Q2	$22.1M	Buy	83,646 +43,858	+110%	+$11.1M	3.83%	4
2023 Q1	$9.85M	Buy	+39,788	New	+$9.74M	2.14%	13

Other funds holding BDX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkman Healthcare Partners's BDX Position: Q2 2025 in Review

Parkman Healthcare Partners sold out of Becton Dickinson (BDX) in Q2 2025, closing a stake of 120,283 shares — an estimated $27.6M sold.

Parkman Healthcare Partners first reported a position in BDX in Q1 2023 and held it in 9 quarters. The position peaked at $27.6M in Q1 2025. 1,517 funds tracked by Wall St. Rank hold BDX as of Q2 2025.

Parkman Healthcare Partners reported no remaining Becton Dickinson position as of Q2 2025 after selling out during the quarter.
Parkman Healthcare Partners sold 120,283 Becton Dickinson shares in Q2 2025, an estimated $27.6M.
Parkman Healthcare Partners first reported a position in Becton Dickinson in Q1 2023 and held it in 9 quarters.
Parkman Healthcare Partners's Becton Dickinson position peaked at $27.6M in Q1 2025.
1,517 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2025.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.